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Non-Hodgkin's lymphomas (NHL) are malignant tumors of lymphatic
tissue. NHL can primarily develop in any tissue or organ. One of the
primary involvements of NHL is the abdominal lymph nodes. Their
frequency constitutes 7.6 - 8.2%.
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To evaluate aggressive NHL with primary abdominal lymph nodes
involvement treatment results.
Retrospective study. Treatment outcomes were studied in 37 patients with aggressive
NHL with primary abdominal lymph nodes involvement, aged between 25 and 73 years
old. Polychemotherapy (PChT) cycles were used for treatment: CHOP
(cyclophosphamide, doxorubicin, vincristine, prednisolone) - in 24 patients and
rituximab + CHOP (R-CHOP) - in 13 patients (table 1).
Complete remissions were obtained in 48.7% of cases. The rate of complete remissions
was higher (69.2%) when PChT R-CHOP was administered, comparing to patients in
whom PChT CHOP (37.5%) was used (table 1.). Progression-free survival (PFS) over 5
years was higher in patients who recieved PChT R-CHOP (75.6%). PFS in the same
terms in cases when PChT CHOP was given was equal to 41.3% (figure 1).
Adding anti-CD20 monoclonal antibodies (rituximab) to the standard PChT CHOP regimen contributed significantly to the increase of complete remissions rate 
and progression-free survival.
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Table 1. Treatment’s results of patients with aggressive NHL with primary







Figure 1. Progression-free survival over 5 years in patients with complete 
remissions obtained when applying the PChT schemes: R-CHOP and CHOP
